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The Opioid Crisis
Abstract
Opioid use and addiction have reached epidemic proportions in Philadelphia, making drug overdose
involving opioids a leading cause of death. Both pharmaceutical and illicit opioids contribute to this crisis.
Opioid sales in Philadelphia more than doubled between 2000 and 2012, and health care providers continue
to prescribe opioid pain medication in greater quantities than medically appropriate. The peak age group for
overdoses is 45-54, an older age group than previously seen. Over-prescribing of opioids contributes to the
recruitment of adults into drug dependence. While use of opioid pain medications usually does not lead to
opioid use disorder, four out of five heroin users nationwide transitioned from original use of prescription
medications. Heroin is easy to obtain, potent and cheap compared to prescription pain medications. There are
estimated to be at least 70,000 heroin users in Philadelphia.
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BACKGROUND
Opioid use and addiction have 
reached epidemic proportions in 
Philadelphia, making drug overdose 
involving opioids a leading cause of 
death. Both pharmaceutical and illicit 
opioids contribute to this crisis. Opioid 
sales in Philadelphia more than 
doubled between 2000 and 2012, 
and health care providers continue 
to prescribe opioid pain medication 
in greater quantities than medically 
appropriate1. The peak age group 
for overdoses is 45-54, an older age 
group than previously seen2. Over-
prescribing of opioids contributes to 
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Figure 1: Rates of opioid-related overdose deaths in Philadelphia, 2016*
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*Philadelphia residents only. The epidemic of overdoses from opioids in Philadelphia.  
Philadelphia Department of Public Health 2016 http://www.phila.gov/health/pdfs/chart%20v2e7.pdf 
†Non-Hispanic
the recruitment of adults into drug 
dependence. While use of opioid pain 
medications usually does not lead to 
opioid use disorder, four out of five 
heroin users nationwide transitioned 
from original use of prescription 
medications3. Heroin is easy to obtain, 
potent and cheap compared to 
prescription pain medications. There 
are estimated to be at least 70,000 
heroin users in Philadelphia4.
Opioid use disorder and overdose 
significantly impact individuals 
and health system utilization in 
Philadelphia. In 2015, there were over 
6,500 emergency department visits for opioid overdoses across the city5. 
Further, for each opioid-related death, 
there were about 12 opioid-related 
emergency department visits. 2016 
drug overdose death rates increased 
across all demographic groups. 
Deaths in men were three times more 
common than deaths in women. While 
all races saw an increase in opioid 
related overdose rates in 2016, whites 
were disproportionately affected 
(Figure 1).
Addiction also impacts the families 
and children of users. Consequences 
of drug misuse that impact families 
include compromised health, higher 
health care costs, violence, child 
abuse and neglect6. Neonatal 
abstinence syndrome (NAS) can 
result from opioid use during 
pregnancy and may interfere with a 
child’s brain development and later 
“We need to figure out how 
we can best assess and share 
opioid risk information to 
patients and their providers 
in a way that meets patients’ 
own needs for pain control 
without having to give them 
excess medications that they 
may not need, want, use and 
could lead to dependency and 
addiction.”
—CPHI Senior Fellow,  
Zachary Meisel, MD
Written by Caroline Stark and Sara Solomon with consultation from Carolyn Cannuscio, 
Jeffrey Hom, and Zachary Meisel
cognitive functioning and behavior. In Philadelphia, the rate of NAS increased 
more than three-fold from 2002 to 20157. Adverse childhood experiences 
(ACE) such as growing up with household substance abuse can have long-term 
effects on children’s health and make substance abuse later in life more likely. 
Approximately 35% of almost 2,000 Philadelphians surveyed grew up with 
substance abuse in their households8.
The epidemic also affects the criminal justice system. Substance use disorder 
prevalence is higher among prison populations than among the general 
population and incarceration itself is a risk factor for developing substance 
use disorder9. Substance use disorders can increase risk of incarceration and 
probability of arrest for nonviolent or drug-related offenses10. 
RECOMMENDATIONS FROM 
THE OPIOID TASK FORCE11
Mayor James Kenney introduced a coordinated effort to confront this issue, with 
The Mayor’s Task Force to Combat the Opioid Epidemic in Philadelphia. The task 
force developed a plan to reduce opioid use disorder and associated morbidity 
and mortality, with the following recommendations:
IMPLEMENTATION, 
MONITORING, AND 
EVALUATION
The City will succeed at implementing 
these steps only with the cooperation 
of many organizations and individuals. 
Monitoring, reporting, and surveillance 
will be established to: 
 Î Develop an opioid epidemic data 
report to establish a baseline and  
monitor the epidemic
 Î Establish use of real-time data to 
support a rapid response plan
 Î Integrate data across systems 
to optimize care for affected 
individuals
 Î Develop an evaluation plan that 
assesses the progress and impact 
of the Mayor’s Opioid Task Force 
Report
 Î Model the program on 
other successful “disease”-
specific program areas within 
Philadelphia’s health department
STRATEGY 1: PREVENTION AND EDUCATION
STRATEGY 2: TREATMENT
■ Conduct a consumer-directed
media campaign about opioid risks.
■ Conduct a public education
campaign about naloxone, which is
used to reverse opioid overdose.
■ Destigmatize opioid use disorder
and its treatment.
■ Increase the provision of
medication-assisted treatment.
■ Expand treatment access and
capacity.
■ Embed withdrawal management
into all levels of care, with an
emphasis on recovery initiation.
■ Implement “warm handoffs” to
treat substance use disorder after
overdose.
■ Provide safe housing, recovery, and
vocational supports.
■ Incentivize providers to enhance
the quality of substance use
disorder screening, treatment, and
workforce.
■ Improve health care professional
education.
■ Establish insurance policies that
support safer opioid prescribing
and appropriate treatment.
■ Expand naloxone availability.
■ Further explore comprehensive
user engagement site(s) (i.e. safe
injection sites).
■ Establish a coordinated rapid
response to “outbreaks.”
■ Address homelessness among
opioid users.
■ Expand the court’s capacity for
diversion to treatment.
■ Expand enforcement capacity in
key areas.
■ Provide substance use disorder
assessment and treatment in
Philadelphia Department of Prisons.
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